ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)

$16.16 0.16 (1%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) News Sources

Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026

06-10-2026

yahoo.com

Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer

08-10-2026

yahoo.com

Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight

13-10-2026

yahoo.com

Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?

19-10-2026

yahoo.com

AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million

21-10-2026

yahoo.com

New Canadian Real-World Evidence at ESMO 2026 Highlights Integration of CLDN18.2 Testing and Targeted Treatment in Clinical Practice

26-10-2026

yahoo.com

Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044, a Novel Immune-Targeted IL-12 Antibody-Cytokine Fusion for Immuno-Oncology

27-10-2026

yahoo.com

Astellas fortifies immuno-oncology pipeline on $1.3bn Audax licensing deal

28-10-2026

pharmaceutical-technology.com

Lilly shuffles business structure; Novartis writes off part of Avidity deal

28-10-2026

biopharmadive.com

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

01-09-2026

yahoo.com

ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) Sentiment Trend

0 25 50 75 100 77 82 85 83 78 60 80 91 72 78 06-10-2026 08-10-2026 13-10-2026 19-10-2026 21-10-2026 26-10-2026 27-10-2026 28-10-2026 01-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) FAQs

toggle

What is the current price of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?

The current price of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is $16.16.


toggle

ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) since the previous trading day is $0.16.


toggle

ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) since the previous trading day is 1%.


toggle

What is the most recent average sentiment score for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?

The most recent average sentiment score for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is 79 out of 100.


toggle

What is the most recent average sentiment for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?

The most recent sentiment for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is .


SEC-8K** Filing Available For ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.